Health

Dr. Smita Das from Stanford University raises a crucial point about the dangers of off-label ketamine use. Her analogy comparing the risks to a “bad trip” emphasizes the potential negative consequences of such practices. This quote serves as a warning to both medical professionals and patients about the importance of using medications as intended and
0 Comments
The concept of “problems in living” encompasses a wide range of difficulties that individuals may face in their day-to-day lives. These challenges can stem from various factors such as psychological, emotional, social, or practical issues, all of which can impact an individual’s overall well-being and quality of life. In addition, these challenges are often closely
0 Comments
California is facing significant challenges when it comes to Medicaid payments for healthcare providers. The case of Hunter Morgan, OD, who had to stop treating Medicaid patients due to low reimbursement rates, is just one example. Despite the efforts of Governor Gavin Newsom and the state Legislature to increase Medicaid coverage, the rates paid to
0 Comments
The recent news of staff at the London clinic attempting to access Kate Middleton’s private medical records raises serious concerns about patient confidentiality. This breach of privacy not only violates the trust between healthcare providers and patients but also highlights the need for stricter security measures to safeguard sensitive information. The decision by New York
0 Comments
The recent approval of the twiist automated insulin delivery system by the FDA marks a significant advancement in diabetes management. This system, developed by Sequel Med Tech and powered by Tidepool, is specifically designed for patients 6 years and older with type 1 diabetes. One of the standout features of this device is its ability
0 Comments
The recent approval by the FDA of atidarsagene autotemcel (arsa-cel; Lenmeldy) marks a significant milestone in the treatment of children with metachromatic leukodystrophy (MLD). This gene therapy is the first of its kind to address children with pre-symptomatic late infantile, pre-symptomatic early juvenile, or early symptomatic early juvenile MLD. The announcement has sparked hope in
0 Comments
In a recent early-phase trial, treatment with raludotatug deruxtecan (R-DXd) has shown to lead to an “exciting” response rate among patients with heavily pretreated, platinum-resistant advanced ovarian cancer. An antibody drug conjugate (ADC) directed against cadherin 6 (CDH6), R-DXd resulted in one complete response and 17 partial responses among 37 evaluable patients, with an overall
0 Comments
Neurological disorders have emerged as the leading cause of ill health and disability worldwide, affecting a staggering 3.4 billion people according to the Global Burden of Disease (GBD) Study. This systematic analysis revealed that neurologic conditions impacted 43.1% of the global population, surpassing cardiovascular diseases to become the primary contributor to the global disease burden
0 Comments